noctiva Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Noctiva, and when can generic versions of Noctiva launch?
Noctiva is a drug marketed by Acerus Pharms and is included in one NDA. There are three patents protecting this drug.
This drug has one hundred and sixteen patent family members in thirty-one countries.
The generic ingredient in NOCTIVA is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Noctiva
A generic version of noctiva was approved as desmopressin acetate by MEITHEAL on October 15th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for noctiva?
- What are the global sales for noctiva?
- What is Average Wholesale Price for noctiva?
Summary for noctiva
International Patents: | 116 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Patent Applications: | 402 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for noctiva |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for noctiva |
DailyMed Link: | noctiva at DailyMed |
![noctiva drug patent expirations Drug patent expirations by year for noctiva](/p/graph/s/t/noctiva-patent-expirations.png)
![Drug Prices for noctiva](/p/graph/drug-price/noctiva.png)
US Patents and Regulatory Information for noctiva
noctiva is protected by three US patents.
Patents protecting noctiva
Safe desmopressin administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS WHO AWAKEN AT LEAST 2 TIMES PER NIGHT TO VOID BY INDUCING AN ANTIDIURETIC EFFECT BY INTRANASALLY ADMINISTERING A PLUME OF DROPLETS COMPRISING A DOSE OF ABOUT 0.05-5 MCG DESMOPRESSIN
Pharmaceutical compositions including low dosages of desmopressin
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Safe desmopressin administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-001 | Mar 3, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-002 | Mar 3, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-001 | Mar 3, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-001 | Mar 3, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-002 | Mar 3, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for noctiva
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-001 | Mar 3, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-002 | Mar 3, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-001 | Mar 3, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-002 | Mar 3, 2017 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for noctiva
See the table below for patents covering noctiva around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 105963834 | 鼻内去氨加压素给药 (Intranasal desmopressin administration) | ⤷ Sign Up |
Japan | 2006502972 | ⤷ Sign Up | |
South Korea | 20110102915 | INTRANASAL DESMOPRESSIN ADMINISTRATION | ⤷ Sign Up |
European Patent Office | 3278809 | ADMINISTRATION SÛRE DE DESMOPRESSINE (SAFE DESMOPRESSIN ADMINISTRATION) | ⤷ Sign Up |
Canada | 2747998 | ADMINISTRATION SECURISEE DE DESMOPRESSINE (SAFE DESMOPRESSIN ADMINISTRATION) | ⤷ Sign Up |
Croatia | P20041152 | PHARMACEUTICAL FORMULATIONS | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for noctiva
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2712622 | LUC00015 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101 |
2712622 | C02712622/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66379 16.03.2018 |
2712622 | 122017000006 | Germany | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504 |
3225249 | 2019C/520 | Belgium | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513 |
3225249 | 300983 | Netherlands | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513 |
3225249 | CA 2019 00023 | Denmark | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |